Time & location: 1:00PM, Virtual
Speaker: Dr. Jennifer E. Van Eyk, PhD, FAHA, FISHR
Professor of Medicine, Cedars-Sinai Medical Center
Advanced Clinical BioSystems Research Institute Director, Barbra Streisand Women’s Heart Center, Basic Science Director, Erika Glazer Endowed Chair in Women’s Heart Health
Fundamental mechanistic research into disease processes has led to an increasing appreciation for the ways in which disease progression and treatment outcomes are influenced by patient heterogeneity. Small changes to low abundant proteins in complex matrices can serve as important indices to reveal important clues about a disease on an individual level, but harnessing this promise rests on our ability to accurately and quantitatively measure proteins with high precision.
Webinar Recording:
Watch on YouTube: https://www.youtube.com/watch?v=90qudBDhGaU
Related Posts
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…
Tertiary Lymphoid Structures in Cancer Immunotherapy: Insights and Perspectives
Tertiary lymphoid structures (TLS) have emerged as critical components of the tumor microenvironment, influencing immune responses and clinical outcomes in cancer.
